Does TEBENTAFUSP-TEBN Cause Product dose omission issue? 37 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 37 reports of Product dose omission issue have been filed in association with TEBENTAFUSP-TEBN. This represents 10.6% of all adverse event reports for TEBENTAFUSP-TEBN.
37
Reports of Product dose omission issue with TEBENTAFUSP-TEBN
10.6%
of all TEBENTAFUSP-TEBN reports
0
Deaths
11
Hospitalizations
How Dangerous Is Product dose omission issue From TEBENTAFUSP-TEBN?
Of the 37 reports, 11 (29.7%) required hospitalization, and 2 (5.4%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TEBENTAFUSP-TEBN. However, 37 reports have been filed with the FAERS database.
What Other Side Effects Does TEBENTAFUSP-TEBN Cause?
Pyrexia (63)
Cytokine release syndrome (59)
Hypotension (47)
Rash (43)
Disease progression (42)
Chills (38)
Malignant neoplasm progression (32)
Nausea (29)
Vomiting (22)
Pruritus (21)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which TEBENTAFUSP-TEBN Alternatives Have Lower Product dose omission issue Risk?
TEBENTAFUSP-TEBN vs TECFIDERA
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M MEDRONATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M OXIDRONATE
TEBENTAFUSP-TEBN vs TECHNETIUM TC-99M PERTECHNETATE